Lithium

Quick links to important sections

Lithium

Selected form

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lithium

Quick Facts

Property Description
Active ingredient Lithium ion (as the carbonate or citrate salt)
Form Tablet, capsule, and oral solution
Pharmacological class Mood stabilizer, Psychotropic agent
Common use Long-term mood regulation and stabilization
Origin Derived (Mineral-based chemical substance)

Lithium: Definition, Classification, and Purpose

Lithium is a prescription-only medicine whose active ingredient is the lithium ion, derived from an alkali metal salt—most commonly formulated as Lithium carbonate or Lithium Citrate. It is officially classified as a psychotropic agent and specifically as a mood stabilizer, a core category of medication essential for long-term mood regulation. Lithium is a standard anti-manic agent known for its efficacy in stabilizing mood and reducing recurrence of episodes. The medicine helps in managing the extreme shifts in emotion associated with certain conditions.

This foundational medication is clinically recognized for its established efficacy in supporting long-term psychiatric care. Unlike many modern drugs, which target specific receptors, the active substance is a simple, small monovalent ion that exerts a broad physiological action by modulating neural communication and cell protection. Lithium's therapeutic effect is linked to its ability to influence multiple intracellular signaling pathways. This mechanism supports the brain's resilience against internal stressors, aiding in sustained emotional balance, a unique property supported by decades of clinical research.


Composition, Forms, and Origin

The active ingredient is the lithium ion, provided pharmacologically as a salt, making it a derived (mineral-based) chemical substance. This is prepared as a single-ingredient product. Some common brands utilizing this INN formulation include Eskalith and Lithobid, both primarily offering forms of Lithium carbonate. The medication is exclusively administered via the oral route of administration. It is available in various dosage form(s), including conventional tablets, capsules, and extended-release formulations. The choice between the Lithium Citrate salt (often used in an oral solution) and the Lithium carbonate salt (typically found in solids) is determined by the formulation, but both deliver the identical therapeutic lithium ion to the body.

Regulatory References

  1. NIH MedlinePlus Drug Information: Lithium
  2. NIH StatPearls: Lithium

What side effects are possible with Lithium?

Possible Side Effects and Safety Information

The medicine's safety profile is defined by effects across multiple physiological systems and a narrow therapeutic range. The potential for Lithium toxicity is a primary constraint, as the therapeutic concentration is close to toxic levels, requiring mandatory serum monitoring as specified in regulatory documents.

Adverse Reactions and System-Organ Effects

Adverse reactions are officially classified by the systems they affect. Effects on the Nervous System include a fine hand tremor, ataxia (loss of coordination), and slurred speech. Common adverse reactions affecting the Renal and Urinary systems are polyuria (frequent urination) and increased thirst (polydipsia). Endocrine effects include potential hypothyroidism and euthyroid goiter (thyroid enlargement).

Classification Example Reactions
Common / Expected Fine hand tremor, polyuria, polydipsia, nausea, weight gain
Serious Adverse Reactions Lithium toxicity, Pseudotumor Cerebri, Encephalopathic Syndrome

Safety Constraints and Special Populations

Certain safety constraints relate to the duration of exposure. While some effects may appear during initial therapy, the risk of chronic conditions, such as the diminution of renal concentrating ability and potential morphologic kidney changes, is associated with long-term use. Older adults require cautious use and monitoring due to potential age-related organ impairment. The official labeling also notes a risk of fetal harm during pregnancy, specifically associated with cardiac malformations.

Overdose and Emergency Response

Lithium overdose, or toxicity, is closely related to elevated serum lithium concentrations, which can occur even at levels near the therapeutic range. The clinical presentation is defined by a spectrum of dose-dependent systemic manifestations. Early documented signs include nausea, vomiting, diarrhea, fine tremor, increasing drowsiness, muscle weakness, and lack of coordination (ataxia).

Overdose can progress to severe or life-threatening outcomes affecting major systems. These include stupor, convulsions, and coma (CNS effects), as well as cardiac arrhythmias, circulatory collapse, and renal failure. The regulatory documentation notes the potential for irreversible brain damage in severe cases. Geriatric patients and those with impaired renal function are noted to be at increased risk of toxicity.

Regulators mandate specific emergency actions. Patients must discontinue the drug and contact a physician immediately upon the appearance of initial symptoms like persistent tremor or diarrhea. Immediate emergency assistance must be sought for severe symptoms such as fainting, abnormal heart beats, or seizures. No specific antidote is known for lithium poisoning; therefore, management is strictly symptomatic and supportive. For severe or life-threatening toxicity, hemodialysis is described as the treatment of choice, with continuous ECG and renal function monitoring being essential.

Therapeutic Uses of Lithium

What Lithium Treats: Main Uses and Benefits

Lithium is a mood stabilizer generally used for conditions characterized by episodic or fluctuating mood patterns, such as Bipolar Disorder, where it helps manage symptoms that interfere with daily functioning. It is commonly used for the management of manic episodes and for the long-term management of Bipolar Disorder.

This medicine is considered relevant for easing high-risk symptoms, including those associated with motor hyperactivity, racing thoughts, and aggressiveness. It may assist in the management of suicidal thoughts and self-harming actions in individuals with mood disorders.

“This continuous management supports the patient during difficult episodes and contributes to easing the impact of severe mood cycling.”

It is commonly used across conditions presenting with acute episodes and situations involving recurrent or episodic manifestations. The application of Lithium provides supportive relief that may assist with managing disruptive manifestations during challenging phases.


Quick Fact: Support for Mood Dysregulation

Lithium is primarily applied in settings involving mood instability, where it contributes to easing the overall symptom load by supporting a more stable emotional environment over time, and assists with functional well-being when symptoms are more noticeable.

Eligibility and Restrictions for Use

Eligibility for Lithium Use

Official regulatory documents define strict population eligibility for using this medicine, largely due to its narrow therapeutic range and dependence on renal clearance.

Classification Population Restriction (As Stated in Label)
Contraindicated Patients with severe renal impairment or significant cardiovascular disease.
Individuals with Brugada Syndrome or a family history of the disorder.
Patients in a state of severe dehydration or sodium depletion.
Not Recommended Breastfeeding women, due to excretion into human milk and risk of infant toxicity.
Pregnant women, particularly during the first trimester, due to potential for fetal harm.
Children younger than 7 years of age (safety and efficacy not established).
Conditional Use Patients with mild to moderate renal impairment (requires lower doses and close monitoring).
Older adults, who require caution and dose adjustment due to age-related decline in kidney function.
Patients with pre-existing thyroid disorders (requires careful monitoring of thyroid function).

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for lithium highlights interactions that primarily affect its concentration in the body or its effects on the central nervous system (CNS).

Documented Interactions Increasing Lithium Concentration

The following drug categories and substances are documented in official labeling to reduce the renal clearance of the lithium ion, leading to an increased risk of toxicity:

  • Diuretics (e.g., Thiazides, Loop diuretics, Spironolactone).
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including specific agents like Indomethacin and Piroxicam.
  • Renin-Angiotensin System Antagonists (e.g., ACE inhibitors and ARBs).
  • Certain Antibiotics (e.g., Metronidazole, Tetracyclines).

Pharmacodynamic and CNS Risks

Combinations with other substances may cause specific toxic syndromes:

  • Serotonergic Drugs: Combining with agents like SSRIs, tricyclic antidepressants, and St. John's Wort may precipitate Serotonin Syndrome due to documented additive CNS effects.
  • Antipsychotics: Co-administration with some neuroleptics (notably Haloperidol) has been associated with the development of an Encephalopathic Syndrome.
  • Neuromuscular Blocking Agents: Lithium is documented to prolong the effects of these agents.

Other Interactions and Restrictions

Substances that officially lower serum lithium concentrations, such as Xanthine derivatives (like Caffeine and Theophylline), may pose a risk of reduced efficacy. Furthermore, maintenance of consistent sodium and fluid intake is a critical, label-based constraint, as low-sodium diets or conditions causing dehydration interfere with lithium clearance. Regulatory documents also note that the interaction risks are generally heightened for geriatric patients due to potentially reduced renal function.

Mechanism of Action

How Lithium Works: Mechanism of Action

Lithium's mechanism of action involves multiple levels of cellular and synaptic modulation. At the intracellular level, it functions as a non-competitive inhibitor of key enzymes, including Inositol Monophosphatase (IMPase) and Glycogen Synthase Kinase-3 (GSK-3). Inhibition of IMPase disrupts the phosphatidylinositol signaling cascade, which alters the recycling of second messengers. Inhibition of GSK-3 promotes the activation of specific pro-survival cascades.

These molecular interactions collectively lead to the modification of neurotransmitter systems. Lithium modulates the activity and sensitivity of several crucial pathways, including those involving serotonin and norepinephrine, influencing their release and receptor function. This alters the equilibrium state of synaptic signaling within specific neural circuits. Furthermore, the downstream effects of GSK-3 inhibition influence the signaling of neurotrophic factors, such as BDNF (Brain-Derived Neurotrophic Factor), affecting processes related to neuronal structure and plasticity. The combined effect on enzyme activity and synaptic dynamics results in changes to systemic physiological regulation.

Dosage and Administration Information

How Lithium is Used: Official Administration Guidelines

Lithium is a prescription medicine delivered exclusively via the oral route of administration through forms such as tablets, capsules, and oral solutions. The method of use is distinct because the dosage is not fixed, but is highly individualized and primarily governed by the mandatory requirement to achieve and maintain a specific therapeutic serum concentration (blood level).


Dosing and Frequency

Treatment regimens are divided into two main usage patterns: acute treatment and long-term maintenance. For acute use, the initial daily dose is titrated upward, often starting with high-level amounts, such as 1800 mg per day, and adjusted based on frequent blood testing. For long-term maintenance, the daily dose is typically lower, frequently ranging from 900 mg to 1200 mg.

Immediate-release formulations are usually taken in divided doses two or three times daily to minimize blood level fluctuations. Conversely, extended-release tablets are often taken once daily.


Administration Requirements

Official instructions require that the medicine be taken with food or immediately after meals to minimize gastrointestinal discomfort. Patients using extended-release forms must not crush, chew, or divide the tablets, as this destroys the controlled-release mechanism. Furthermore, consistent and adequate fluid and salt intake is a critical administration constraint, as changes in sodium and water balance directly impact the lithium concentration in the blood.

Population Adjustments

Labeling mandates specific dose modifications for certain groups. Older adults require a lower starting dose and a slower titration process. Patients with impaired kidney function also require a substantial dose reduction, reflecting the drug’s renal clearance pathway.

Recent Clinical Evidence

Lithium remains a foundational medication in the management of bipolar disorder, with recent systematic reviews and meta-analyses confirming its long-term efficacy.

Efficacy and Relapse Prevention

Clinical guidelines often recommend lithium as a first-line treatment for its established role in preventing future mood episodes. Studies have consistently demonstrated that long-term lithium treatment reduces the risk of overall relapse, specifically showing a protective effect against manic and hypomanic episodes. Evidence also suggests a benefit in preventing depressive relapses, although this effect has been noted as potentially less robust across some trial data.

Unique Therapeutic Properties

Beyond its mood-stabilizing effects, one of the most significant and unique findings repeatedly supported by research is lithium's association with a reduced risk of suicidal behavior in individuals with mood disorders. Furthermore, clinical and preclinical studies continue to explore lithium's neuroprotective properties, suggesting that it may influence cellular signaling pathways in the central nervous system. These proposed actions include the modulation of key enzymes and trophic factors associated with cell survival and neuronal stability.

Safety and Monitoring

Due to its narrow therapeutic window, clinical trials emphasize the requirement for consistent blood-level monitoring to maintain optimal concentration and mitigate risk. Long-term use has been associated with potential effects on the kidney and thyroid function, underscoring the necessity for regular functional testing. Despite the requirement for careful monitoring, recent consensus among experts confirms lithium's essential role in personalized, evidence-based treatment plans.

Frequently Asked Questions (FAQ)

Common questions about Lithium (FAQ)

Q: How does Lithium compare to other medicines used for bipolar disorder?

A: Official information describes Lithium as an established foundation or first-line treatment for managing bipolar disorder. Research and regulatory documents consistently support its specific use in preventing future mood episodes. Furthermore, studies highlight its unique association with reduced suicidal behavior in individuals with mood disorders.

Q: What does it mean that Lithium has a narrow therapeutic index?

A: A narrow therapeutic index is an official safety constraint indicating that the difference between the dose needed for desired effects and the dose that can cause toxicity is small. This constraint is the primary reason for the requirement of regular serum monitoring (blood testing) to ensure the amount of the drug in the body remains within the proper range.

Q: How long does it usually take for Lithium to start working?

A: According to official patient information and guidelines, it may take several weeks for the drug’s full mood-stabilizing effects to become noticeable. This duration is generally needed to determine the medicine's appropriateness for an individual's treatment plan.

Q: Is it possible to have an allergic reaction to Lithium?

A: Official information lists a contraindication for patients with a known allergy to any medicine containing lithium. While rare, signs of a serious allergic reaction, such as hives, difficulty breathing, or swelling of the face, are described in official patient information and should prompt immediate contact with a healthcare professional.

Q: Does Lithium interact with caffeine?

A: Regulatory interaction documents classify caffeine as a Xanthine derivative that may lower the concentration of lithium in the blood. This reduction in the drug level poses a risk of reduced efficacy or impact on the treatment's desired effect.

Q: Does Lithium affect blood pressure?

A: Official documents note that certain high blood pressure medicines, such as ACE inhibitors and ARBs, are documented to significantly increase the concentration of lithium in the body. This increase raises the risk of lithium toxicity, which is why close monitoring is often performed when these combinations are used.

Q: Are there different brands or generic versions of Lithium?

A: Yes, the active ingredient is the lithium ion, which is available as different chemical salts, most commonly Lithium Carbonate or Lithium Citrate. It is available both as generic versions and under various brand names, such as Eskalith and Lithobid.

Q: Can I drink alcohol while taking Lithium?

A: Official patient guidelines advise against or recommend limiting alcohol use, particularly when first starting the medicine. Alcohol may cause increased drowsiness and can also affect the body's hydration and sodium levels, which may alter the concentration of lithium in the blood.

Q: Can men taking Lithium still father children?

A: Official regulatory documents detail specific risks and restrictions for pregnant and breastfeeding women, but they do not state specific restrictions or risks regarding effects on male fertility or the ability to father children.

Q: What happens if a person suddenly stops taking Lithium?

A: Official patient information advises against stopping the medicine suddenly. Studies indicate that abrupt discontinuation may increase the risk of a relapse, which is a return of the original mood symptoms the medicine was prescribed to manage.

Q: Is Lithium addictive?

A: No. Official patient education materials explicitly describe that Lithium, which is classified as a mood stabilizer, is not addictive.

Q: Is Lithium related to the element found in batteries?

A: Yes. Official drug descriptions confirm that the active ingredient is the lithium ion, which is derived from an alkali metal salt. This substance is the same chemical element used in other industrial applications.

Q: Why is it called a 'salt'?

A: Official drug descriptions refer to the medicine as a 'salt' because the active component, the lithium ion, is formulated chemically with another substance, such as carbonate or citrate, to form a chemical salt. This is a standard process for making a mineral-based chemical substance into a usable medicine.

Q: Can Lithium affect memory or concentration?

A: Official adverse reaction lists may include reports of 'brain fog,' confusion, or memory problems, especially with long-term use. These are considered effects on the central nervous system.

Q: Is there research looking into new uses for Lithium?

A: Yes. While its primary regulatory use is for mood stabilization, authoritative sources describe that research continues to examine Lithium's unique therapeutic properties. This includes ongoing studies focused on its neuroprotective effects and influence on cell pathways in the brain.

Q: What are the signs of a serious skin reaction linked to Lithium?

A: Signs of a serious skin reaction are generally described under allergic/hypersensitivity symptoms. These may include a severe rash, itching, hives, or swelling. Official guidance describes these symptoms as requiring immediate consultation with a healthcare professional.

Q: Can being sick (e.g., having the flu) change my Lithium level?

A: Yes, regulatory guidelines advise that during illnesses like the flu or gastro-enteritis that cause fever, vomiting, or profuse sweating, there is an increased risk of dehydration. Since dehydration can significantly increase lithium levels in the blood, the dose may need to be reviewed by a healthcare provider.

Q: Does Lithium interact with common cold or allergy medicines?

A: Official interaction documents warn that some non-prescription medicines, such as certain antihistamines or decongestants, may cause increased drowsiness, confusion, or impaired coordination when taken with Lithium due to additive effects on the central nervous system.

Q: Are there any restrictions on driving or operating machinery while taking Lithium?

A: Official patient information advises caution, stating the medicine may impair the ability to drive or use machinery. Individuals should wait until they know how the medicine affects them, particularly regarding potential side effects like drowsiness or dizziness.

Q: Is it normal to feel tired when first starting Lithium?

A: Drowsiness or feeling tired is listed among the common side effects that may occur, particularly when first starting the medicine or during the initial adjustment period of therapy.

Q: Does Lithium cause dry mouth?

A: Official patient information and adverse reaction lists include dry mouth as a common side effect of the medicine.

Q: What happens if I miss a dose of Lithium?

A: Official guidelines on missed doses typically advise against taking a double dose the following day. They generally suggest taking the missed dose as soon as it is remembered, provided it is not too far past the usual time, but this information is not personal medical advice and individual circumstances should be discussed with a healthcare provider.

Q: Is hair loss a possible side effect of Lithium?

A: Yes. Official patient information lists thinning of hair or hair loss as a possible side effect of the medicine.

Q: Can changes in diet impact the effectiveness of Lithium?

A: Regulatory documents state that changes in the amount of salt (sodium) consumed can directly affect the level of lithium in the blood. For this reason, regulatory documents state that maintaining a consistent diet and fluid intake is a key factor in keeping lithium levels stable.

Q: Is there a difference in how fast different forms of Lithium work (e.g., tablet vs. extended release)?

A: Yes. Official documents state that extended-release formulations are specifically designed to release the medicine slower and achieve more stable concentrations over time. Conversely, immediate-release formulations release the medicine quickly, leading to higher peak blood levels shortly after administration.

How should Lithium be stored and disposed of?

How to Store and Dispose of Lithium?

Lithium carbonate solid oral dosage forms must be stored under specific environmental and container conditions defined in official regulatory labeling to ensure product stability and prevent exposure.


Storage Conditions

Lithium is required to be stored at Controlled Room Temperature (CRT), defined as 20° to 25° Celsius (68° to 77° Fahrenheit), with permitted excursions up to 30° C. The medication must be kept in its original container, which must be tightly closed, and stored away from moisture.

Child Safety: A mandatory requirement is to keep all lithium medication out of the sight and reach of children.

Disposal Instructions

Official guidance for disposal of unused or expired product prioritizes utilizing an authorized drug take-back program. If a take-back option is unavailable, the medication should be disposed of in the household trash after being mixed with an undesirable substance (such as dirt or coffee grounds) and sealed in a bag, as per official non-flush list instructions.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lithium found in:

A-Z Index: